Unibest
← Back to patent-cliff list

CAS 872-85-5

isonicotinaldehyde

Codes: DONE-009

Application context (from source-drug indications)

Alzheimer's diseaseMemantine Hydrochloride/Donepezil HydrochlorideLewy body dementiaDonepezil HydrochlorideAlzheimer's diseaseDonepezil HydrochlorideDementiaDonepezil HydrochlorideMemory impairmentDonepezil HydrochlorideMild cognitive impairmentDonepezil HydrochlorideOsteoporosisDonepezil Hydrochloride

Source drugs (routes using this intermediate)

DrugTierExpiry
Memantine Hydrochloride/Donepezil HydrochlorideTier C — Watch / trade-
Donepezil HydrochlorideTier B — Position early-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Memantine Hydrochloride/Donepezil HydrochlorideOptimised routesteps: 3total yield: /
(chloromethyl)benzene→isonicotinaldehyde→5,6-dimethoxy-2-(piperidin-4-ylmethyl)-2,3-dihydro-1H-inden-1-one→2-bromo-5,6-dimethoxy-2,3-dihydro-1H-inden-1-one→5,6-dimethoxy-3'-(pyridin-4-yl)spiro[indene-2,2'-oxiran]-1(3H)-one
Donepezil HydrochlorideOptimised routesteps: 3total yield: /
(chloromethyl)benzene→isonicotinaldehyde→5,6-dimethoxy-2-(piperidin-4-ylmethyl)-2,3-dihydro-1H-inden-1-one→2-bromo-5,6-dimethoxy-2,3-dihydro-1H-inden-1-one→5,6-dimethoxy-3'-(pyridin-4-yl)spiro[indene-2,2'-oxiran]-1(3H)-one

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.